A novel pancreatic cancer vaccine shows promise in improving survival when added to standard treatment, according to new research out of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine. The Phase 2 data was presented at the Annual Meeting of the Society ...

By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic's campus in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study. The light, attached to a probe, measures changes in ...

CLEVELAND A novel pancreatic cancer vaccine shows promise in improving survival when added to standard treatment, according to new research out of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine. The Phase 2 data was presented today (embargoed 11:00 am ET) ...

By Alan Mozes HealthDay Reporter TUESDAY, May 22 (HealthDay News) -- Two preliminary studies suggest that some headway is being made in both the detection and treatment of pancreatic cancer. On the treatment front, researchers from two Cleveland institutions said they have ...

By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic's campus in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study.

Jack Andraka, 15, of Crownsville, Md. was awarded first place for his new method to detect pancreatic cancer at this year's Intel International Science and Engineering Fair, a program of Society for Science & the Public. Based on diabetic test paper, Jack created a simple dip-stick sensor to test blood ...

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention. The paper was published in Cancer Research. ...

(University of California - San Diego) Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention. The paper will be published May ...

A non-invasive way to detect the exact location of very small life-threatening tumors in the pancreas (insulinomas) has been discovered by a team of researchers in Switzerland. This new technique will help surgeons to successfully remove the tumors that can be less than 1 centimeter in diameter. Professor Emanuel ...

A new class of cancer drug which targets a faulty gene might be effective in treating some aggressive pancreatic cancers, researchers from Cancer Research UK's Cambridge Research Institute and the Wellcome Trust Sanger Institute reported in the journal Nature. Pancreatic cancer kills approximately 37,000 people in the USA and 8,000 ...

Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature.